High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11427-11433

  Wang, Lin ^a   Chen, Yan Jie ^a   Xu, Kai ^a   Wang, Ya Yun ^a   Shen, Xi Zhong ^a   Tu, Rui Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

EOC; Predictor; Prognosis; UCH37

Indexed keywords

TUMOR MARKER; UBIQUITIN THIOLESTERASE; UCHL5 PROTEIN, HUMAN;

CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN THIOLESTERASE;

EID: 84927788737     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2446-3     Document Type: Article

References (17)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.
2. Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115(18):4118–26. doi:10.1002/cncr.24461.
3. Rota M, Pasquali E, Scotti L, Pelucchi C, Tramacere I, Islami F, et al. Alcohol drinking and epithelial ovarian cancer risk a systematic review and meta-analysis. Gynecol Oncol. 2012;125(3):758–63. doi:10.1016/j.ygyno.2012.03.031.
4. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–79. doi:10.1146/annurev.biochem.67.1.425.
5. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503–33. doi:10.1146/annurev.biochem.70.1.503.
6. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82(2):373–428. doi:10.1152/physrev.00027.2001.
7. Wilkinson KD. Cell biology: unchaining the condemned. Nature. 2002;419(6905):351–3. doi:10.1038/419351a.
8. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426(6968):895–9. doi:10.1038/nature02263.
9. Chung CH, Baek SH. Deubiquitinating enzymes: their diversity and emerging roles. Biochem Biophys Res Commun. 1999;266(3):633–40. doi:10.1006/bbrc.1999.1880.
10. Chen YJ, Ma YS, Fang Y, Wang Y, Fu D, Shen XZ. Power and promise of ubiquitin carboxyl-terminal hydrolase 37 as a target of cancer therapy. Asian Pacific journal of cancer prevention: APJCP. 2013;14(4):2173–9.
11. Al-Shami A, Jhaver KG, Vogel P, Wilkins C, Humphries J, Davis JJ, et al. Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. PLoS One. 2010;5(10):e13654. doi:10.1371/journal.pone.0013654.
12. Rolen U, Kobzeva V, Gasparjan N, Ovaa H, Winberg G, Kisseljov F, et al. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol Carcinog. 2006;45(4):260–9. doi:10.1002/mc.20177.
13. Chen Y, Fu D, Xi J, Ji Z, Liu T, Ma Y, et al. Expression and clinical significance of UCH37 in human esophageal squamous cell carcinoma. Dig Dis Sci. 2012;57(9):2310–7. doi:10.1007/s10620-012-2181-9.
14. Fang Y, Mu J, Ma Y, Ma D, Fu D, Shen X. The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma. Mol Cell Biochem. 2012;359(1–2):59–66. doi:10.1007/s11010-011-0999-7.
15. Fang Y, Fu D, Tang W, Cai Y, Ma D, Wang H, et al. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19. Biochim Biophys Acta. 2013;1833(3):559–72. doi:10.1016/j.bbamcr.2012.11.020.
16. Fang Y, Fu D, Shen XZ. The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim Biophys Acta. 2010;1806(1):1–6. doi:10.1016/j.bbcan.2010.03.001.
17. Wang L, Chen YJ, Hou J, Wang YY, Tang WQ, Shen XZ et al. Expression and clinical significance of BIRC6 in human epithelial ovarian cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014. doi:10.1007/s13277-014-1641-6.